Inflammation appears as high prostate imaging– reporting and data system scores on prostate magnetic resonance imaging (MRI) leading to false positive mri fusion biopsy

Elizabeth Rourke, Abhijit Sunnapwar, Daniel Mais, Vishal Kukkar, John Digiovanni, Dharam Kaushik, Michael A. Liss

Research output: Contribution to journalArticle

Abstract

Purpose: To investigate if inflammation as a potential cause of false-positive lesions from recent UroNav magnetic resonance imaging (MRI) fusion prostate biopsy patients. Materials and Methods: We retrospectively identified 43 men with 61 MRI lesions noted on prostate MRI before MRI ultrasound-guided fusion prostate biopsy. Men underwent MRI with 3T Siemens TIM Trio MRI system (Siemens AG, Germany), and lesions were identified and marked in DynaCAD system (Invivo Corporation, USA) with subsequent biopsy with MRI fusion with UroNav. We obtained targeted and standard 12-core needle biopsies. We retrospectively reviewed pathology reports for inflammation. Results: We noted a total of 43 (70.5%) false-positive lesions with 28 having no cancer on any cores, and 15 lesions with cancer noted on systematic biopsy but not in the target region. Of the men with cancer, 6 of the false positive lesions had inflammation in the location of the targeted region of interest (40.0%, 6/15). However, when we examine the 21/28 lesions with an identified lesion on MRI with no cancer in all cores, 54.5% had inflammation on prostate biopsy pathology (12/22, p=0.024). We noted the highest proportion of inflammation. Conclusions: Inflammation can confound the interpretation of MRI by mimicking prostate cancer. We suggested focused efforts to differentiate inflammation and cancer on prostate MRI.

Original languageEnglish (US)
Pages (from-to)388-395
Number of pages8
JournalInvestigative and Clinical Urology
Volume60
Issue number5
DOIs
StatePublished - Jan 1 2019
Externally publishedYes

Fingerprint

Information Systems
Prostate
Magnetic Resonance Imaging
Inflammation
Biopsy
Neoplasms
Prostatic Neoplasms
Pathology
Large-Core Needle Biopsy
Germany

Keywords

  • Inflammation
  • Magnetic resonance imaging
  • Prostatic neoplasms
  • Prostatitis

ASJC Scopus subject areas

  • Urology

Cite this

Inflammation appears as high prostate imaging– reporting and data system scores on prostate magnetic resonance imaging (MRI) leading to false positive mri fusion biopsy. / Rourke, Elizabeth; Sunnapwar, Abhijit; Mais, Daniel; Kukkar, Vishal; Digiovanni, John; Kaushik, Dharam; Liss, Michael A.

In: Investigative and Clinical Urology, Vol. 60, No. 5, 01.01.2019, p. 388-395.

Research output: Contribution to journalArticle

Rourke, Elizabeth ; Sunnapwar, Abhijit ; Mais, Daniel ; Kukkar, Vishal ; Digiovanni, John ; Kaushik, Dharam ; Liss, Michael A. / Inflammation appears as high prostate imaging– reporting and data system scores on prostate magnetic resonance imaging (MRI) leading to false positive mri fusion biopsy. In: Investigative and Clinical Urology. 2019 ; Vol. 60, No. 5. pp. 388-395.
@article{6a9e5c80f4ee46dd9f96e77805ae2829,
title = "Inflammation appears as high prostate imaging– reporting and data system scores on prostate magnetic resonance imaging (MRI) leading to false positive mri fusion biopsy",
abstract = "Purpose: To investigate if inflammation as a potential cause of false-positive lesions from recent UroNav magnetic resonance imaging (MRI) fusion prostate biopsy patients. Materials and Methods: We retrospectively identified 43 men with 61 MRI lesions noted on prostate MRI before MRI ultrasound-guided fusion prostate biopsy. Men underwent MRI with 3T Siemens TIM Trio MRI system (Siemens AG, Germany), and lesions were identified and marked in DynaCAD system (Invivo Corporation, USA) with subsequent biopsy with MRI fusion with UroNav. We obtained targeted and standard 12-core needle biopsies. We retrospectively reviewed pathology reports for inflammation. Results: We noted a total of 43 (70.5{\%}) false-positive lesions with 28 having no cancer on any cores, and 15 lesions with cancer noted on systematic biopsy but not in the target region. Of the men with cancer, 6 of the false positive lesions had inflammation in the location of the targeted region of interest (40.0{\%}, 6/15). However, when we examine the 21/28 lesions with an identified lesion on MRI with no cancer in all cores, 54.5{\%} had inflammation on prostate biopsy pathology (12/22, p=0.024). We noted the highest proportion of inflammation. Conclusions: Inflammation can confound the interpretation of MRI by mimicking prostate cancer. We suggested focused efforts to differentiate inflammation and cancer on prostate MRI.",
keywords = "Inflammation, Magnetic resonance imaging, Prostatic neoplasms, Prostatitis",
author = "Elizabeth Rourke and Abhijit Sunnapwar and Daniel Mais and Vishal Kukkar and John Digiovanni and Dharam Kaushik and Liss, {Michael A.}",
year = "2019",
month = "1",
day = "1",
doi = "10.4111/icu.2019.60.5.388",
language = "English (US)",
volume = "60",
pages = "388--395",
journal = "Investigative and Clinical Urology",
issn = "2466-0493",
publisher = "Korean Urological Association",
number = "5",

}

TY - JOUR

T1 - Inflammation appears as high prostate imaging– reporting and data system scores on prostate magnetic resonance imaging (MRI) leading to false positive mri fusion biopsy

AU - Rourke, Elizabeth

AU - Sunnapwar, Abhijit

AU - Mais, Daniel

AU - Kukkar, Vishal

AU - Digiovanni, John

AU - Kaushik, Dharam

AU - Liss, Michael A.

PY - 2019/1/1

Y1 - 2019/1/1

N2 - Purpose: To investigate if inflammation as a potential cause of false-positive lesions from recent UroNav magnetic resonance imaging (MRI) fusion prostate biopsy patients. Materials and Methods: We retrospectively identified 43 men with 61 MRI lesions noted on prostate MRI before MRI ultrasound-guided fusion prostate biopsy. Men underwent MRI with 3T Siemens TIM Trio MRI system (Siemens AG, Germany), and lesions were identified and marked in DynaCAD system (Invivo Corporation, USA) with subsequent biopsy with MRI fusion with UroNav. We obtained targeted and standard 12-core needle biopsies. We retrospectively reviewed pathology reports for inflammation. Results: We noted a total of 43 (70.5%) false-positive lesions with 28 having no cancer on any cores, and 15 lesions with cancer noted on systematic biopsy but not in the target region. Of the men with cancer, 6 of the false positive lesions had inflammation in the location of the targeted region of interest (40.0%, 6/15). However, when we examine the 21/28 lesions with an identified lesion on MRI with no cancer in all cores, 54.5% had inflammation on prostate biopsy pathology (12/22, p=0.024). We noted the highest proportion of inflammation. Conclusions: Inflammation can confound the interpretation of MRI by mimicking prostate cancer. We suggested focused efforts to differentiate inflammation and cancer on prostate MRI.

AB - Purpose: To investigate if inflammation as a potential cause of false-positive lesions from recent UroNav magnetic resonance imaging (MRI) fusion prostate biopsy patients. Materials and Methods: We retrospectively identified 43 men with 61 MRI lesions noted on prostate MRI before MRI ultrasound-guided fusion prostate biopsy. Men underwent MRI with 3T Siemens TIM Trio MRI system (Siemens AG, Germany), and lesions were identified and marked in DynaCAD system (Invivo Corporation, USA) with subsequent biopsy with MRI fusion with UroNav. We obtained targeted and standard 12-core needle biopsies. We retrospectively reviewed pathology reports for inflammation. Results: We noted a total of 43 (70.5%) false-positive lesions with 28 having no cancer on any cores, and 15 lesions with cancer noted on systematic biopsy but not in the target region. Of the men with cancer, 6 of the false positive lesions had inflammation in the location of the targeted region of interest (40.0%, 6/15). However, when we examine the 21/28 lesions with an identified lesion on MRI with no cancer in all cores, 54.5% had inflammation on prostate biopsy pathology (12/22, p=0.024). We noted the highest proportion of inflammation. Conclusions: Inflammation can confound the interpretation of MRI by mimicking prostate cancer. We suggested focused efforts to differentiate inflammation and cancer on prostate MRI.

KW - Inflammation

KW - Magnetic resonance imaging

KW - Prostatic neoplasms

KW - Prostatitis

UR - http://www.scopus.com/inward/record.url?scp=85071978868&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85071978868&partnerID=8YFLogxK

U2 - 10.4111/icu.2019.60.5.388

DO - 10.4111/icu.2019.60.5.388

M3 - Article

C2 - 31501802

AN - SCOPUS:85071978868

VL - 60

SP - 388

EP - 395

JO - Investigative and Clinical Urology

JF - Investigative and Clinical Urology

SN - 2466-0493

IS - 5

ER -